manual tissue arrayer mta-1 (Beecher Instruments Inc)
90
Structured Review
Beecher Instruments Inc
manual tissue arrayer mta-1
Manual Tissue Arrayer Mta 1, supplied by Beecher Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+arrayer/manual+tissue+arrayer+mta+1/pm39408855-149-16-20
Average 90 stars, based on 1 article reviews
Manual Tissue Arrayer Mta 1, supplied by Beecher Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manual+arrayer/manual+tissue+arrayer+mta+1/pm39408855-149-16-20
Average 90 stars, based on 1 article reviews
manual tissue arrayer mta-1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma Article Snippet: The TMAs were constructed using a manual Article Title: ERBB2 and PTPN2 g ene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab Article Snippet: Three Article Title: Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance Article Snippet: Three samples (0.6 mm Article Title: Met and its ligand HGF are associated with clinical outcome in breast cancer Article Snippet: The TMAs were constructed using a manual Article Title: Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer Article Snippet: Three TMAs were constructed using the manual Article Title: Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer Article Snippet: A technician then transferred 3×0.6 mm Article Title: Clinical Significance of TTF-1 Protein Expression and TTF-1 Gene Amplification in Lung Adenocarcinoma Article Snippet: Three tumour samples (0.6‐mm cores) from each case were included into paraffin donor blocks using a manual Blocking Assay:Article Title: Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy Article Snippet: © 2 0 11 T H E A U T H O R S 1 2 5 0 B J U I N T E R N A T I O N A L © 2 0 11 B J U I N T E R N A T I O N A L | 1 0 9 , 1 2 5 0 – 1 2 5 7 | doi:10.1111/j.1464-410X.2011.10433.x What ’ s known on the subject? and What does the study add?. Unlike most other cancers mutations of the p53 gene ( TP53 ), typically indicated by increased p53 expression, are rare in renal cell carcinomas (RCC) and there is no evidence that mutation of TP53 is associated with outcome or treatment response.. However, whilst TP53 mutations are not linked with outcome, p53 expression is as we show here. |